Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J AITCHISON

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Brain and Behavior|September 29, 2018
Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis useRohit J Lodhi, Yabing Wang, David Rossolatos, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2012
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram responseTimothy R Powell, Leonard C Schalkwyk, Andrew L Heffernan, et al.
Molecular Psychiatry|May 7, 2008
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatmentS J Bull, P Huezo-Diaz, E B Binder, et al.
Molecular Neuropsychiatry|November 7, 2018
Associations between the <i>LEP</i> -2548G/A Promoter and Baseline Weight and between <i>LEPR</i> Gln223Arg and Lys656Asn Variants and Change in BMI <i>z</i> Scores in Arab Children and Adolescents Treated with RisperidoneNoor B Almandil, Rohit J Lodhi, Hongyan Ren, et al.
Translational Psychiatry|August 15, 2018
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)Hongyan Ren, Chiara Fabbri, Rudolf Uher, et al.
Psychopharmacology|March 13, 2015
Exploring the role of drug-metabolising enzymes in antidepressant side effectsKaren Hodgson, Katherine E Tansey, Rudolf Uher, et al.
Schizophrenia Research|September 16, 2009
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatmentValeria Mondelli, Paola Dazzan, Nilay Hepgul, et al.
Journal of Affective Disorders|September 24, 2009
History of suicide attempts among patients with depression in the GENDEP projectNader Perroud, Rudolf Uher, Joanna Hauser, et al.
Psychological Medicine|June 10, 2010
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosisM Aas, P Dazzan, V Mondelli, et al.
Journal of Psychopharmacology (Oxford, England)|November 22, 2013
Genetic differences in cytochrome P450 enzymes and antidepressant treatment responseKaren Hodgson, Katherine Tansey, Mojca Zvezdana Dernovsek, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Brain and Behavior|September 29, 2018
Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis useRohit J Lodhi, Yabing Wang, David Rossolatos, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2012
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram responseTimothy R Powell, Leonard C Schalkwyk, Andrew L Heffernan, et al.
Molecular Psychiatry|May 7, 2008
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatmentS J Bull, P Huezo-Diaz, E B Binder, et al.
Molecular Neuropsychiatry|November 7, 2018
Associations between the <i>LEP</i> -2548G/A Promoter and Baseline Weight and between <i>LEPR</i> Gln223Arg and Lys656Asn Variants and Change in BMI <i>z</i> Scores in Arab Children and Adolescents Treated with RisperidoneNoor B Almandil, Rohit J Lodhi, Hongyan Ren, et al.
Translational Psychiatry|August 15, 2018
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)Hongyan Ren, Chiara Fabbri, Rudolf Uher, et al.
Psychopharmacology|March 13, 2015
Exploring the role of drug-metabolising enzymes in antidepressant side effectsKaren Hodgson, Katherine E Tansey, Rudolf Uher, et al.
Schizophrenia Research|September 16, 2009
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatmentValeria Mondelli, Paola Dazzan, Nilay Hepgul, et al.
Journal of Affective Disorders|September 24, 2009
History of suicide attempts among patients with depression in the GENDEP projectNader Perroud, Rudolf Uher, Joanna Hauser, et al.
Psychological Medicine|June 10, 2010
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosisM Aas, P Dazzan, V Mondelli, et al.
Journal of Psychopharmacology (Oxford, England)|November 22, 2013
Genetic differences in cytochrome P450 enzymes and antidepressant treatment responseKaren Hodgson, Katherine Tansey, Mojca Zvezdana Dernovsek, et al.
Pageof 18